Description
Product details
Transfer 10000 IU Injection is an erythropoiesis-stimulating medicine used to support the production of red blood cells in patients with certain forms of anaemia. It may be prescribed for chronic kidney disease (CKD)-associated anaemia, chemotherapy-related anaemia, and selected cases of anaemia associated with HIV treatment. The medicine acts on the bone marrow to promote red blood cell formation, helping healthcare professionals manage low haemoglobin levels and reduced oxygen-carrying capacity. Benefits CKD-Associated Anaemia Advanced kidney disease can interfere with the body's normal regulation of red blood cell production. Transfer 10000 IU Injection helps stimulate erythropoiesis and may improve anaemia-related symptoms such as persistent fatigue, weakness and reduced energy, including in suitable dialysis patients. Chemotherapy-Related Anaemia Some chemotherapy medicines can suppress red blood cell formation. Transfer 10000 IU may be prescribed for appropriate patients to support haemoglobin management and red blood cell production during cancer treatment. Anaemia Associated with HIV Treatment In selected patients receiving certain medicines for HIV, this injection may be considered for the management of treatment-associated anaemia. Its use depends on clinical evaluation and laboratory monitoring. How to Use Transfer 10000 IU Injection should be administered only according to a healthcare professional's instructions. The dose, route and treatment frequency are determined according to haemoglobin levels, underlying condition and individual response. Possible Side Effects Reported side effects may include: High blood pressure Nausea or vomiting Headache and dizziness Fever or chills Skin rash Joint, bone or muscle pain Cough Difficulty sleeping Injection-site irritation Mouth inflammation Changes in blood glucose or blood cell counts Vascular blockage or blood clots Seek medical advice if any reaction persists, becomes severe or causes concern. Important Precautions Regular monitoring of haemoglobin and blood pressure may be required during therapy. Patients should inform their healthcare professional about cardiovascular conditions, previous blood clots and other medicines being taken.
